Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kyle O. Lee
Observed names:
Kyle Lee,
Kyle O Lee,
Lee, Kyle O.
Institutions:
City Of Hope National Medical Center,
Saint John's Health Center,
City of Hope
Observed institutions:
St. Michael's Hospital,
City Of Hope National Medical Center,
University of British Columbia,
University of Toronto,
North York General Hospital,
Saint John's Health Center,
City of Hope,
Beckman Research Institute
show all 8
ORCID:
0000-0002-9361-3804
Observed ORCID:
0000-0002-9361-3804
OpenAlex ID:
A5026756204
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma
2023
·
Nazli Dizman
, Ameish Govindarajan
, et al.
·
Clinical Genitourinary Cancer
·
34
Diagnosis and Management of Atopic Dermatitis for Primary Care Providers
2020
·
Patrick Fleming
, Yue Bo Yang
, et al.
·
The Journal of the American Board of Family Medicine
·
32
PDF
Decoupling the role of RORγt in the differentiation and effector function of T H 17 cells
2022
·
Xiancai Zhong
, Hongmin Wu
, et al.
·
Science Advances
·
17
The Gut Microbiome and Metastatic Renal Cell Carcinoma
2023
·
Luis Meza
, Matthew Feng
, et al.
·
Journal of Clinical Medicine
·
15
PDF
Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy.
2021
·
Jeremy Strain
, Maria Leis
, et al.
·
Skin therapy letter
·
11
Outcome for Neoadjuvant Treatment of Parotid Gland Adamantinoma-Like Ewing Sarcoma: Case Report and Review of Literatures
2022
·
Christina H. Wei
, Lester D. R. Thompson
, et al.
·
International Journal of Surgical Pathology
·
9
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research
2023
·
Hedyeh Ebrahimi
, Daniela V. Castro
, et al.
·
Clinical Genitourinary Cancer
·
8
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy
2023
·
Daniela V. Castro
, Sweta R. Prajapati
, et al.
·
British Journal of Urology
·
7
PDF
Association between time-of-day of the immune checkpoint inhibitor (ICI) infusion and disease outcomes among patients with metastatic renal cell carcinoma (mRCC).
2023
·
Nazli Dizman
, Ameish Govindarajan
, et al.
·
Journal of Clinical Oncology
·
5
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion
2025
·
Benjamin D. Mercier
, Ameish Govindarajan
, et al.
·
Cancer Medicine
·
4
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study
2022
·
Daniela V. Castro
, Zeynep B. Zengin
, et al.
·
Cancer Investigation
·
2
Factors Associated With Residual Disease on Re-Excision Specimens After Breast-Conserving Surgery for Breast Cancer
2025
·
Kyle Lee
, Angela Pallesi
, et al.
·
Annals of Surgical Oncology
·
1
Evaluation of eligibility criteria in advanced prostate cancer clinical trials based on ASCO-FCR recommendations.
2023
·
Matthew I. Feng
, Sweta R. Prajapati
, et al.
·
Journal of Clinical Oncology
PDF
Evaluation of eligibility criteria in contemporary renal cell carcinoma based on ASCO-FCR recommendations.
2023
·
Sweta R. Prajapati
, Matthew I. Feng
, et al.
·
Journal of Clinical Oncology
Assessment of eligibility criteria in advanced urothelial cancer (aUC) trials based on ASCO-FCR recommendations.
2023
·
Daniela V. Castro
, Matthew I. Feng
, et al.
·
Journal of Clinical Oncology
Lack of immune homology with vaccine preventable pathogens suggests childhood immunizations do not protect against SARS-CoV-2 through adaptive cross-immunity
2020
·
Weihua Guo
, Kyle O. Lee
, et al.
·
medRxiv
PDF
Show more works
View as search
Works count:
17
Citation count:
145
H-index:
7
I10-index:
5
Year
Topic
Type